Bookmark Email Print this page

Research & Development in Life Sciences

An in-depth article series

Publish date:

Deloitte’s research & development (R&D) feature series is a selection of short articles that address critical challenges faced by the industry. Intended for Life Sciences R&D executives, these articles address multiple business areas and outline innovative and distinctive solutions to current and potential industry challenges. The series covers a broad and diverse set of vital business components including strategic vision, operational re-design, technology, talent management, and tax among others. Each article represents a snapshot of Deloitte’s point of view and is intended to foster further thinking and conversation regarding a particular issue.

 Deloitte Image

Innovative and Productive Pharmaceutical Research through Strategic Capability Management 
Life Sciences companies are faced with the challenge of maintaining a sustainable pipeline and driving growth while controlling costs. This article shows how managing R&D as an integrated set of capabilities has helped companies become more agile, efficient and better positioned to innovate in a changing industry.

 

 Deloitte Image  

Secondary Uses of Electronic Health Record (EHR) Data in Life Science Research, Development and Post-marketing Surveillance 
Most Life Sciences R&D functions are under increasing pressure to improve innovation, reduce development inefficiencies and advance product safety. Patient-level data, collected through EHR systems, offers one promising avenue for redefining R&D and revolutionizing the life sciences value chain.

 

 Deloitte Image  

Executing & Sustaining R&D Strategy
Given the length of the R&D process and other pressures on the industry, Life Sciences organizations cannot afford to have their R&D strategies delayed or partially implemented because of poor execution. By focusing on more effective execution from the outset, R&D organizations can increase the likelihood of achieving the expected benefits of their strategies.

 

Life Sciences R&D talent strategies: Remaining competitive in the emerging markets talent pool Life Sciences R&D Talent Strategies: Remaining Competitive in the Emerging Markets Talent Pool 
This paper outlines key challenges and potential solutions for R&D talent management in emerging markets, with a focus on China and India.

Partnering Strategies in Life Sciences R&D Partnering Strategies in Life Sciences R&D 
This article describes a portfolio-based partnership approach that recognizes the unique economic profiles and risks of a diverse portfolio. Understanding each portfolio segment can help Life Science companies better identify the partner or partners best suited to meet their needs and help them retain the capabilities that provide competitive advantage.

Additional articles that will be released in 2009:

  • Scenario Planning in Life Sciences - Planning for Uncertainty
  • Strategic Management of the Research Pipeline
  • R&D Tax Credits
  • The Value of Early Stage Life Science Companies
  • Leveraging IT to Enable the Transition to the Virtual R&D Model

Related Content: 

Resources: Catch the Life Sciences Wave 
Overview: Life Sciences 

Last updated

Stay Connected

  • E-mail Us
  • Subscribe
  • Send RFP
  • Careers
  • RSS Feeds